Mone, Pasquale et al
"Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes." Journal of Pharmacology and Experimental Therapeutics
384.1
(2023):
116-122.
Web. 19 April. 2024.